0000950123-19-004982.txt : 20190515 0000950123-19-004982.hdr.sgml : 20190515 20190515060539 ACCESSION NUMBER: 0000950123-19-004982 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190515 DATE AS OF CHANGE: 20190515 EFFECTIVENESS DATE: 20190515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SV Health Investors, LLC CENTRAL INDEX KEY: 0001587143 IRS NUMBER: 861154144 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16271 FILM NUMBER: 19824884 BUSINESS ADDRESS: STREET 1: ONE BOSTON PLACE STREET 2: 201 WASHINGTON STREET, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 617-367-8100 MAIL ADDRESS: STREET 1: ONE BOSTON PLACE STREET 2: 201 WASHINGTON STREET, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 FORMER COMPANY: FORMER CONFORMED NAME: SV Life Sciences Advisers, LLC DATE OF NAME CHANGE: 20130918 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001587143 XXXXXXXX 03-31-2019 03-31-2019 SV Health Investors, LLC

ONE BOSTON PLACE 201 WASHINGTON STREET, SUITE 3900 BOSTON MA 02108

13F HOLDINGS REPORT 028-16271 Y The filing of this report shall not be deemed an admission, for purposes of Section 13(f), 13(d), 13(g), or 16(a) under the Securities Exchange Act of 1934, as amended, and the rules thereunder, or for any other purpose, that the Reporting Manager or any other person (including Other Managers or Other Included Managers named herein) is the beneficial owner of any securities. SV Health Investors, LLC (formerly SV Life Sciences Advisers, LLC), a Delaware limited liability company ("Investors"), is an institutional investment manager subject to Section 13(f) of the Securities Exchange Act of 1934 and the rules promulgated thereunder. SV Life Sciences Fund IV, L.P. ("SVLS IV LP") and SV Life Sciences Fund IV Strategic Partners, L.P. ("Strategic Partners IV" and together with SVLS IV LP, the "Fund IV Entities"), and SV Life Sciences Fund V, L.P. ("SVLS V LP") and SV Life Sciences Fund V Strategic Partners, L.P. ("Strategic Partners V" and together with SVLS V LP, the "Fund V Entities"), and SV Life Sciences Fund VI, L.P. ("SVLS VI LP") and SV Life Sciences Fund VI Strategic Partners, L.P. ("Strategic Partners VI" and together with SVLS VI LP, the "Fund VI Entities"), which are each Delaware limited partnerships (the Fund IV Entities, the Fund V Entities and the Fund VI Entities together, the "Funds"), directly own certain security positions reported by Investors, which is the investment adviser of the Funds. SV Life Sciences Fund IV (GP), L.P., a Delaware limited partnership ("SVLS IV GP") is the general partner of the Fund IV Entities, and SVLSF IV, LLC, a Delaware limited liability company is the general partner of SVLS IV GP. SV Life Sciences Fund VI (GP), L.P., a Delaware limited partnership ("SVLS VI GP") is the general partner of the Fund VI Entities, and SVLSF VI, LLC, a Delaware limited liability company is the general partner of SVLS VI GP. Certain of the security positions reported by Investors are also being reported by SVLS IV GP, SVLSF IV, LLC, SVLS VI GP and SVLSF VI, LLC (together, the "GPs"). Each of SVLS IV GP, SVLSF IV, LLC and Investors may be deemed to share voting power and control over the shares held by the Fund IV Entities. Each of SVLS VI GP, SVLSF VI, LLC and Investors may be deemed to share voting power and control over the shares held by the Fund VI Entities. Investors may also be deemed to share voting power and control over the shares held by the Fund V Entities. Each of the GPs and Investors disclaim beneficial ownership of the shares held by the Funds except to the extent of any pecuniary interest therein. Brent M. Faduski (617) 367-8100 /s/ Brent M. Faduski Boston MA 05-15-2019 4 8 170475 false 1 028-16272 SVLSF IV, LLC 2 028-16273 SV Life Sciences Fund IV (GP), L.P. 3 028-19256 SVLSF VI, LLC 4 028-19255 SV Life Sciences Fund VI (GP), L.P. INFORMATION TABLE 2 form13fInfoTable.xml INFORMATION TABLE FOR FORM 13F TRANSENTERIX INC COM NEW 89366M201 15784 6631832 SH OTR 1,2 0 6631832 0 OCULAR THERAPEUTIX INC COM 67576A100 2494 628236 SH OTR 1,2 0 628236 0 CATABASIS PHARMACEUTICALS IN COM NEW 14875P206 2263 285765 SH OTR 0 285765 0 KALVISTA PHARMACEUTICALS INC COM 483497103 52419 1831548 SH OTR 1,2 0 1831548 0 DECIPHERA PHARMACEUTICALS INC COM 24344T101 28739 1238198 SH OTR 3,4 0 1238198 0 X4 Pharmaceuticals COM 98420X103 5423 311490 SH OTR 3,4 0 311490 0 AVROBIO INC COM 05455M100 42572 1930704 SH OTR 3,4 0 1930704 0 SUTRO BIOPHARMA INC COM 869367102 20781 1824542 SH OTR 1,2 0 1824542 0